K, P., VS, M., SK, D., & D, M. (2019). Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC. Dove Medical Press.
Chicago Style (17th ed.) CitationK, Pal, Madamsetty VS, Dutta SK, and Mukhopadhyay D. Co-delivery of Everolimus and Vinorelbine via a Tumor-targeted Liposomal Formulation Inhibits Tumor Growth and Metastasis in RCC. Dove Medical Press, 2019.
MLA (8th ed.) CitationK, Pal, et al. Co-delivery of Everolimus and Vinorelbine via a Tumor-targeted Liposomal Formulation Inhibits Tumor Growth and Metastasis in RCC. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.